-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
OnKure Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2020 to 2023.
- OnKure Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $826K, a 42.2% decline year-over-year.
- OnKure Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $4.21M, a 15.9% decline year-over-year.
- OnKure Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $5.11M, a 18.3% increase from 2022.
- OnKure Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $4.32M, a 11% increase from 2021.
- OnKure Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $3.89M, a 890% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)